A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Vaccine

• Publication date

  2009-12-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2009.09.022PMID 19778518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.

  2009cited by this paper
• Nanotechnology in vaccine delivery☆

  2008cited by this paper
• Crystal Structures of the 70-kDa Heat Shock Proteins in Domain Disjoining Conformation *

  2008cited by this paper
• Heat shock protein 70 fused to or complexed with hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice.

  2008cited by this paper
• Freeing vaccine adjuvants from dangerous immunological dogma

  2008cited by this paper
• Human recombinant heat shock protein 70 affects the maturation pathways of dendritic cells in vitro and has an in vivo adjuvant activity

  2008cited by this paper
• Crystal Structures of the 70-kDa Heat Shock Proteins in Domain Disjoining Conformation*

  2008cited by this paper
• Hypothalamic Control of the Pituitary‐Gonadal Axis in Higher Primates: Key Advances over the Last Two Decades

  2008cited by this paper
• Construction of Novel Vaccines on the Basis of Virus-Like Particles: Hepatitis B Virus Proteins as Vaccine Carriers

  2008cited by this paper
• Virus‑like particles as a vaccine delivery system: Myths and facts

  2008cited by this paper
• Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.

  2008cited by this paper
• Medicinal Protein Engineering

  2008cited by this paper
• Heat shock protein derivatives for delivery of antigens to antigen presenting cells.

  2008cited by this paper
• Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.

  2008cited by this paper
• Inhibition effects on liver tumors of BALB/c mice bearing H22 cells by immunization with a recombinant immunogen of GnRH linked to heat shock protein 65.

  2007cited by this paper
• Vaccine adjuvants revisited.

  2007cited by this paper
• Virus-like particles—universal molecular toolboxes

  2007cited by this paper
• Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis.

  2006cited by this paper
• Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).

  2006cited by this paper
• Hepatitis B Virus Capsid-like Particles Can Display the Complete, Dimeric Outer Surface Protein C and Stimulate Production of Protective Antibody Responses against Borrelia burgdorferi Infection*

  2006cited by this paper
• Asparaginase display of human cholesteryl ester transfer protein (CETP) B cell epitopes for inducing high titers of anti-CETP antibodies in vivo.

  2006cited by this paper
• Cloning, expression, and purification of a highly immunogenic recombinant gonadotropin-releasing hormone (GnRH) chimeric peptide.

  2006cited by this paper
• Ten tandem repeats of β-hCG 109–118 enhance immunogenicity and anti-tumor effects of β-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65

  2006cited by this paper
• Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.

  2006cited by this paper
• Direct Comparison of a Stable Isolated Hsp70 Substrate-binding Domain in the Empty and Substrate-bound States*

  2006cited by this paper
• A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula

  2005cited by this paper
• Structural dynamics of the DnaK-peptide complex.

  2005cited by this paper
• A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant.

  2005cited by this paper
• The immunogenicity of recombinant and dimeric gonadotrophin-releasing hormone vaccines incorporating a T-helper epitope and GnRH or repeated GnRH units.

  2004cited by this paper
• Mosaic hepatitis B virus core particles presenting the complete preS sequence of the viral envelope on their surface.

  2004cited by this paper
• The solution structure of the bacterial HSP70 chaperone protein domain DnaK(393–507) in complex with the peptide NRLLLTG

  2003cited by this paper
• 8 Artificial Genes for Chimeric Virus-Like Particles

  2003cited by this paper
• Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

  2002cited by this paper
• Aluminum salts in vaccines--US perspective.

  2002cited by this paper
• Artificial DNA :methods and applications

  2002cited by this paper
• Roles of heat-shock proteins in innate and adaptive immunity

  2002cited by this paper
• RNA Polymerase II Holoenzyme Modifications Accompany Transcription Reprogramming in Herpes Simplex Virus Type 1-Infected Cells

  2001cited by this paper
• HBV Core Particles as a Carrier for B Cell/T Cell Epitopes

  2001cited by this paper
• Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble

  2000cited by this paper
• Structural insights into substrate binding by the molecular chaperone DnaK

  2000cited by this paper
• Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

  1999cited by this paper
• Hepatitis B core particles as a universal display model: a structure‐function basis for development

  1999cited by this paper
• Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy

  1997cited by this paper
• The Expression of HCG Epitope Fused to Hepatits B Virus Core Antigen.

  1996cited by this paper
• Structural Analysis of Substrate Binding by the Molecular Chaperone DnaK

  1996cited by this paper
• Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy.

  1994cited by this paper
• Specificity of DnaK-peptide binding.

  1994cited by this paper
• Isolation of rabbit liver branched chain alpha-ketoacid dehydrogenase and regulation by phosphorylation.

  1982cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Effect of active immunization with recombinant GnRH6-kisspeptin fusion protein on reproductive function in male rats.

  2025cites this paper
• Expression, purification and refolding of pro-MMP-2 from inclusion bodies of E. coli.

  2023cites this paper
• EspB and HtpG interact with the type III-A CRISPR/Cas system of Mycobacterium tuberculosis

  2023cites this paper
• Inhibition of RM-1 prostate carcinoma and eliciting robust immune responses in the mouse model by using VEGF-M2-GnRH3-hinge-MVP vaccine

  2018cites this paper
• Construction , expression and purification of recombinant HBcAg-MAGE-A 3 therapeutic cancer vaccine

  2016cites this paper
• Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.

  2016cites this paper
• Presenting heterologous epitopes with hepatitis B core-based virus-like particles

  2014cites this paper
• Detection of antibodies against customized epitope: use of a coating antigen employing VEGF as fusion partner

  2014cites this paper
• Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.

  2013cites this paper
• Hepatitis B core–based virus–like particles to present heterologous epitopes

  2013cites this paper
• Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2

  2012cites this paper
• Preparation of a peptide vaccine against GnRH by a bioprocess system based on asparaginase.

  2010cites this paper
• Immunization with a recombinant GnRH vaccine fused to heat shock protein 65 inhibits mammary tumor growth in vivo

  2010cites this paper